Biocryst Pharmaceuticals Inc. is a biotechnology company that designs, develops, and commercializes novel oral medications for rare diseases, focusing on treatments for hereditary angioedema and other conditions.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!